Free Trial

GRAIL (GRAL) Competitors

GRAIL logo
$46.58 -0.40 (-0.85%)
Closing price 09/24/2025 04:00 PM Eastern
Extended Trading
$46.54 -0.03 (-0.08%)
As of 09/24/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GRAL vs. BTSG, OPCH, SHC, WGS, CON, SGRY, PRVA, HTFL, VCYT, and CELC

Should you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include BrightSpring Health Services (BTSG), Option Care Health (OPCH), Sotera Health (SHC), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

GRAIL vs. Its Competitors

BrightSpring Health Services (NASDAQ:BTSG) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

BrightSpring Health Services has a beta of 2.27, meaning that its stock price is 127% more volatile than the S&P 500. Comparatively, GRAIL has a beta of 3.18, meaning that its stock price is 218% more volatile than the S&P 500.

In the previous week, GRAIL had 2 more articles in the media than BrightSpring Health Services. MarketBeat recorded 6 mentions for GRAIL and 4 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.68 beat GRAIL's score of 0.21 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GRAIL
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BrightSpring Health Services has a net margin of 0.55% compared to GRAIL's net margin of -329.86%. BrightSpring Health Services' return on equity of 9.29% beat GRAIL's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services0.55% 9.29% 2.64%
GRAIL -329.86%-16.64%-14.02%

BrightSpring Health Services has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$11.27B0.43-$18.06M$0.3187.84
GRAIL$125.60M13.37-$2.03B-$13.11-3.55

BrightSpring Health Services currently has a consensus target price of $27.10, indicating a potential downside of 0.48%. GRAIL has a consensus target price of $31.50, indicating a potential downside of 32.37%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities research analysts plainly believe BrightSpring Health Services is more favorable than GRAIL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.92
GRAIL
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

BrightSpring Health Services beats GRAIL on 11 of the 14 factors compared between the two stocks.

Get GRAIL News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRAL vs. The Competition

MetricGRAILMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.69B$3.15B$5.78B$10.42B
Dividend YieldN/A2.36%5.68%4.61%
P/E Ratio-3.5520.7676.0126.42
Price / Sales13.37447.47560.21127.79
Price / Cash1.6345.9137.5661.52
Price / Book0.639.8313.046.39
Net Income-$2.03B-$52.73M$3.29B$271.13M
7 Day Performance17.66%1.84%0.84%0.93%
1 Month Performance41.49%7.48%5.04%7.52%
1 Year Performance256.66%19.92%69.67%30.06%

GRAIL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRAL
GRAIL
0.5344 of 5 stars
$46.58
-0.9%
$31.50
-32.4%
+251.8%$1.69B$125.60M-3.551,360
BTSG
BrightSpring Health Services
1.7626 of 5 stars
$27.18
+2.8%
$27.10
-0.3%
+78.9%$4.69B$11.27B87.6835,000
OPCH
Option Care Health
4.8616 of 5 stars
$27.89
-2.1%
$35.75
+28.2%
-12.6%$4.62B$5.00B22.318,088Positive News
Analyst Forecast
SHC
Sotera Health
2.3962 of 5 stars
$16.23
+1.1%
$16.00
-1.4%
-6.8%$4.56B$1.10B202.903,000
WGS
GeneDx
2.3645 of 5 stars
$122.04
-1.5%
$104.13
-14.7%
+192.3%$3.56B$305.45M2,440.801,200
CON
Concentra Group Holdings Parent
3.1171 of 5 stars
$21.26
-4.0%
$27.50
+29.3%
-10.7%$2.84B$1.90B17.8711,250
SGRY
Surgery Partners
3.1105 of 5 stars
$21.60
-1.2%
$33.00
+52.8%
-32.9%$2.80B$3.11B-15.1015,000Positive News
PRVA
Privia Health Group
4.4102 of 5 stars
$22.34
-2.0%
$28.58
+27.9%
+28.7%$2.80B$1.74B203.111,140Trending News
Analyst Forecast
Analyst Revision
HTFL
Heartflow
N/A$32.89
-1.5%
$35.80
+8.8%
N/A$2.71BN/A0.00699Trending News
Earnings Report
Analyst Forecast
VCYT
Veracyte
3.8609 of 5 stars
$31.87
+3.2%
$40.90
+28.3%
-3.1%$2.43B$479.13M96.58790Positive News
CELC
Celcuity
1.4714 of 5 stars
$55.07
+0.3%
$56.50
+2.6%
+278.0%$2.33BN/A-15.9640Analyst Forecast

Related Companies and Tools


This page (NASDAQ:GRAL) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners